Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.
Journal Information
Full Title: Europace
Abbreviation: Europace
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest: A.A.W. is a member of the scientific advisor board of ARMGO (unpaid) and a member of the scientific advisor board of Thryvv therapeutics (unpaid). E.J.B. is a consultant for Boston Scientific. M.J.A. has royalty/equity relationship with AliveCor, ARMGO, anumana, Pfizer, Trhyvv therapeutics. M.J.A. is a consultant for Abbott, Boston scientific, Daiichi Sankyo, Invitae, Tenaya Therapeutics, BioMarin Pharmaceutical, Bristol Myers Squibb, Illumina, Medtronic, and UpToDate. E.F. is supported by the Max’s foundation. All other authors report no disclosures."
"Funding This article was supported by the AEPC junior members research grant 2019 (P.J.P.)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025